Toret, ErsinAy, YılmazAksoylar, SerapKarapınar, Tuba HilkayOymak, Yeşim2020-12-012020-12-0120192147-94452587-2478https://doi.org/10.4274/jpr.galenos.2018.33254https://app.trdizin.gov.tr//makale/TXpjNU5UQXdNQT09https://hdl.handle.net/11454/67174Type II Griscelli Syndrome (GS) is caused by a mutation in the RAB27A gene and usually manifests with silvery-gray hair, immune deficiency and the development of hemophagocytic lymphohistiocytosis (HLH). A hematopoietic stem cell transplantation is the curative treatment for HLH and reduced-intensity conditioning prevents the morbidity/mortality in the transplantation related to myeloablative conditioning. We report on a 21-month old boy with cerebral involvement of HLH related to GS.en10.4274/jpr.galenos.2018.33254info:eu-repo/semantics/openAccess0-BelirlenecekArticle63252255N/A